Isabel Rodriguez-Barraquer

Isabel Rodriguez-Barraquer publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Isabel Rodriguez-Barraquer sits on this spectrum.

Isabel Rodriguez-Barraquer D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Isabel Rodriguez-Barraquer sits on this spectrum.

Best Publications

• A systematic review of antibody mediated immunity to coronaviruses: kinetics, correlates of protection, and association with severity.

  Angkana T. Huang;Bernardo Garcia-Carreras;Matt D. T. Hitchings;Bingyi Yang

  842
  Citations

• Assessing the global threat from Zika virus

  Justin Lessler;Lelia H. Chaisson;Lauren M. Kucirka;Lauren M. Kucirka;Qifang Bi

  454
  Citations

• Reconstruction of antibody dynamics and infection histories to evaluate dengue risk.

  Henrik Salje;Derek A.T. Cummings;Derek A.T. Cummings;Isabel Rodriguez-Barraquer;Leah C. Katzelnick

  297
  Citations

• Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment.

  Neil M. Ferguson;Isabel Rodríguez-Barraquer;Ilaria Dorigatti;Luis Mier-y-Teran-Romero

  284
  Citations

• Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region

  Isabel Rodriguez-Barraquer;Federico Costa;Federico Costa;Federico Costa;Eduardo J. M. Nascimento;Nivison Nery Júnior;Nivison Nery Júnior

  270
  Citations

• A systematic review of antibody mediated immunity to coronaviruses: Antibody kinetics, correlates of protection, and association of antibody responses with severity of disease

  Angkana T. Huang;Bernardo Garcia-Carreras;Matt D.T. Hitchings;Bingyi Yang

  253
  Citations

• Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms.

  Michael J. Peluso;Amelia N. Deitchman;Leonel Torres;Nikita S. Iyer

  253
  Citations

• Mapping global variation in dengue transmission intensity.

  Lorenzo Cattarino;Isabel Rodriguez-Barraquer;Natsuko Imai;Derek A. T. Cummings

  248
  Citations

• Enhancing disease surveillance with novel data streams: challenges and opportunities

  Benjamin M. Althouse;Samuel V. Scarpino;Lauren Ancel Meyers;Lauren Ancel Meyers;John W. Ayers

  232
  Citations

• Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave

  Unknown

  227
  Citations

• The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study

  Stefan Flasche;Mark Jit;Isabel Rodríguez-Barraquer;Laurent Coudeville

  227
  Citations

• Sources of persistent malaria transmission in a setting with effective malaria control in eastern Uganda: a longitudinal, observational cohort study.

  Chiara Andolina;John C Rek;Jessica Briggs;Joseph Okoth

  220
  Citations

• From Re-Emergence to Hyperendemicity: The Natural History of the Dengue Epidemic in Brazil

  Isabel Rodriguez-Barraquer;Marli T. Cordeiro;Cynthia Braga;Wayner V. de Souza

  200
  Citations

• Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations.

  Bing Sun;Norina Tang;Michael J. Peluso;Nikita S. Iyer

  176
  Citations

• Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.

  Juliet E. Bryant;Andrew S. Azman;Andrew S. Azman;Matthew J. Ferrari;Benjamin F. Arnold

  164
  Citations

• Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure.

  Isabel Rodriguez-Barraquer;Emmanuel Arinaitwe;Prasanna Jagannathan;Moses R Kamya

  147
  Citations

• Long-term circulation of Zika virus in Thailand: an observational study

  Kriangsak Ruchusatsawat;Pattara Wongjaroen;Arisara Posanacharoen;Isabel Rodriguez-Barraquer

  137
  Citations

• SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay.

  Michael J. Peluso;Saki Takahashi;Jill Hakim;J. Daniel Kelly

  129
  Citations

• Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus

  Leah C. Katzelnick;Leah C. Katzelnick;Ana Coello Escoto;Benjamin D. McElvany;Christian Chávez

  129
  Citations

• Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased

  Saki Takahashi;Bryan Greenhouse;Isabel Rodríguez-Barraquer

  126
  Citations